Abstract
Several independent studies have demonstrated that there is a degradation of membrane phospholipids during myocardial ischemia. At present, most of the data support the initial activation of a phospholipase A pathway of phospholipid degradation. The extent of total phospholipid degradation is in the nanomole per gram wet weight quantity, as opposed to ischemic liver, in which the extent of phospholipid depletion approaches the micromole per gram wet weight level. However, in vitro studies suggest that calcium permeability properties and other myocardial cell membrane functions are sensitive to nanomole levels of phospholipid degradation. Clearly, further work is necessary in intact cell and heart preparations to correlate the degradation of phospholipid with the development of irreversible membrane injury during ATP depletion and hypoxia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chien, K. R., Abrams, J., Serroni, A., Martin, J. T., and Farber, J. L. 1978. Accelerated phospholipid degradation and associated membrane dysfunction in irreversible ischemic liver cell injury. J. Biol. Chem. 253:4809–4817.
Chien, K. R., Abrams, J., Pfau, R. G., and Farber, J. L. 1977. Prevention by chlorpromazine of ischemic liver cell death. Am. J. Pathol. 88:539–558.
Chien, K. R., Sherman, C., Mittnacht, S., and Farber, J. L. 1980. Microsomal membrane structure and function consequent to calcium activation of an endogenous phospholipase. Arch. Biochem. Biophys. 205:614–622.
Farber, J. L., Chien, K. R., and Mittnacht, S. 1982. The pathogenesis of irreversible cell injury in ischemia. Am. J. Pathol. 102:271–278.
Wattiaux, R., and Wattiaux-De Coninck, S. 1980. Reversible and irreversible alterations of lysosomes in ischemic rat liver: Effects of chlorpromazine. Biochem. Pharmacol. 29:963–966.
Matsumoto, J., Tanaka, T., Gamo, M., Saito, K., and Honjo, I. 1981. Phospholipid metabolism of dog liver under hypoxic conditions induced by ligation of the hepatic artery. Biochim. Biophys. Acta 664:527–537.
Patel, Y., Stewart, J., Matthys, E., and Venkatacham, M. A. 1982. Renal cortical free fatty acid and 1,2 diglyceride in renal ischemic injury. Clin. Res. 30:541A.
Smith, M. W., Collan, Y., Kaling, M., and Trump, B. F. 1980. Changes in mitochondrial lipids of rat kidney during ischemia. Biochim. Biophys. Acta. 618:192–201.
Bazan, N. G. 1970. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 218:1–14.
Van der Vusse, G. I., Roeman, T.H. M., Prinzen, F. W., Coumans, W. A., and Reneman, R. S. 1982. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ. Res. 50:538–546.
Corr, P. D., Snyder, D. W., Lee, B. I., Gross, R. W., Keim, C. R., and Sobel, B. E. 1982. Pathophysiological concentrations of lysophosphatides and the slow response. Am. J. Physiol. 243 : H187–H195.
Hsueh, W., Isaksan, P. C., and Needleman, P. 1977. Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins 13:1073–1090.
Vasdev, S. C., Kako, K. J., and Biro, G. P. 1979. Phospholipid composition of cardiac mitochondria and lysosomes in experimental myocardial ischemia in the dog. J. Mol. Cell. Cardiol. 11:1195–1200.
Shaikh, N. A., and Downar, E. 1981. Time course of changes in porcine myocardial phospholipid levels during ischemia: A reassessment of the lysolipid hypothesis. Circ. Res. 49:316–325.
Chien, K. R., Reeves, J. P., Buja, L. M., Bonte, F., Parkey, R. W., and Willerson, J. T. 1981. Phospholipid alterations in canine ischemic myocardium: Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca + 2 permeability defect. Circ. Res. 48:711–719.
Hostetler, K. Y., and Hall, L. B. 1980. Phospholipase C activity of rat tissues. Biochem. Biophys. Res. Commun. 96:388–393.
Weglicki, W. B. 1980. Degradation of phospholipids of myocardial membranes. In: Wildenthal, K. (ed.), Degradative Processes in Heart and Skeletal Muscle. pp. 377–388. Elsevier/North-Holland, Amsterdam.
Prescott, S. M., and Majerus, P. W. 1981. The fatty acid composition of phosphatidylinositol from thrombin-stimulated human platelets. J. Biol. Chem. 256:579–582.
Gross, R. E., and Sobel, B. E. 1982. Lysophosphatidylcholine metabolism in the rabbit heart. J. Biol. Chem. 257:6702–6708.
Sobel, B. E., Corr, P. B., Robison, A. K., Goldstein, R. A., Witkowski, F. X., and Klein, M. S. 1978. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J. Clin. Invest. 62:546–553.
Mogelson, S., Wilson, G. E., and Sobel, B. E. 1980. Characterization of rabbit myocardial phospholipids with 31P nuclear magnetic resonance. Biochim. Biophys. Acta 619:688.
Shaikh, N. A., and Downar, E. 1983. Ischemic induced phospholipase(s) activation in isolated perfused cat hearts. J. Mol. Cell. Cardiol. 15:171.
Chien, H. R., Han, A., Bush, L. R., Buja, L. M., and Willerson, J. T. 1984. Accumulation of unesterified arachidonate in ischemic canine myocardium: Relationship to a phosphatioylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids. Circ. Res. 54:313–322.
Gunn, M. D., Sen, H., Kim, Y. M., Revtyak, G., Buja, L. M., Campbell, W. B., and Chien, K. R. Arachidonate metabolism of cultured myocardial cells during ATP depletion: Deacylation of arachidonate without conversion to prostaglandins. Submitted.
Prinzen, F. W., van der Vusse, G. J., Coumans, W. A., Roemen, T. H. M., and Reneman, R. S. 1983. Accumulation of non-esterified fatty acids in ischemic myocardium in relation to residual blood flow and ATP content. J. Mol. Cell. Cardiol. 15:370.
Bakardjieva, A., Galla, H. J., and Helmreich, E. J. M. 1979. Modulation of the ß-receptor adenylate cyclase interactions in cultured Chang liver cells by phospholipid enrichment. Biochem. 18:3016–3023.
Hasin, Y., Sapoznikov, D., Stein, O., and Stein, Y. 1982. Effect of fatty acid composition of rat heart myocytes on their electrical activity. J. Mol. Cell. Cardiol. 14:163–171.
Langer, G. A., Frank, J. S., and Philipson, K. D. 1981. Correlation of alterations in cation exchange and sarcolemmal ultrastructure produced by neuraminidase and phospholipases in cardiac cell tissue culture. Circ Res. 49:1289–1299.
Higgins, T. J. C., Bailey, P. J., and Allsopp, D. 1982. Interrelationship between cellular metabolic status and susceptibility of heart cells to attack by phospholipase. J. Mol. Cell. Cardiol. 14:645–654.
Shaikh, N. A., and Downar, E. 1983. Effects of exogenous and endogenous lysophospholipids on the excitability of cardiac muscle and Purkinje fibres of sheep heart. J. Mol. Cell. Cardiol . 15:170.
Sedlis, S. P., Corr, P. B., Sobel, B. E., and Ahumada, G. G. 1983. Lysophosphatidylcholine potentiates Ca+ + accumulation in rat cardiac myocytes. Am. J. Physiol. 13:H32–H38.
Katz, A. M. 1982. Membrane derived lipids and the pathogenesis of ischemic myocardial damage. J. Mol. Cell. Cardiol. 14:627–632.
Ashavaid, T. F., Colvin, R. A., Mac Alister, T., Messineo, F. C., and Katz, A. M. 1983. Fatty acid effects on Na/Ca exchange in sarcolemmal vesicles. J. Mol. Cell. Cardiol. 15:362.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chien, K.R., Willerson, J.T., Buja, L.M. (1985). Phospholipid Alterations and Membrane Injury during Myocardial Ischemia. In: Harris, P., Poole-Wilson, P.A. (eds) Advances in Myocardiology. Advances in Myocardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1287-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1287-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1289-6
Online ISBN: 978-1-4757-1287-2
eBook Packages: Springer Book Archive